52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience F.J. Melgosa Ramos, A. Mateu Puchades, J. Matáix-Díaz, L. Schneller-Pavelescu, I. Belinchón-Romero, S. Santos Alarcón

Long-Term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Multicenter Study From Spain J.F. Silvestre, S. Santos-Alarcón, A. Mengual-Sendra, V. Zaragoza, M.P. Ortega-García, M. Rodriguez, E. Monte-Boquet, R.F. Ruiz de Apodaca, N. Pérez Prior, F.J. Miquel, J. Borras-Blasco

Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis A. Azevedo, T. Torres